Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03162913
Other study ID # 12523
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2017
Est. completion date October 20, 2023

Study information

Verified date March 2024
Source USDA Human Nutrition Research Center on Aging
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is being conducted to assess the effect of dietary strawberry supplementation on cognition and mobility in obese middle-aged and older adults. It is hypothesized that plant compounds, present in strawberries, may improve cognition and mobility.


Description:

Previously, the investigators have shown that dietary berry fruit are able to reverse several parameters of brain aging, as well as age-related motor and cognitive deficits when fed to aged rats. They have shown that strawberry, in particular, can reduce oxidative stress and pro-inflammatory signaling in the brain and improve both mobility and cognition. A recent study also found that the addition of two servings of strawberry per day for 3 months could significantly improve verbal and spatial memory among healthy older adults, particularly on tests with high cognitive demand. These effects may reflect the direct effects of strawberries' bioactive and neuroavailable polyphenols on brain signaling or their indirect effects through antioxidant and anti-inflammatory pathways. However, participants in that study were selected from a healthy aging population, which made it difficult to detect changes in balance, mobility, and the less complex cognitive tasks. Therefore, the investigators are proposing the current study to assess the effects of dietary strawberry on mobility and cognition among a compromised population, obese older adults, who are at increased risk for cardiovascular, metabolic, and neurodegenerative disease. The risk for heart disease, diabetes, stroke, cancer and dementia increases in direct relation to overweight and obesity measures, and research now shows that obesity is a primary cause of mental deterioration among the middle-aged and senior populations. In this study, obese older adults (55-75yo, BMI 30-36) will consume 24g/d freeze-dried strawberry or control powder for 3 months and complete a battery of lifestyle, mobility, and cognitive tests at 3 time points. The investigators hypothesize that supplementing obese older adults' diet with strawberry will improve performance on complex tasks involving mobility and cognition.


Recruitment information / eligibility

Status Completed
Enrollment 47
Est. completion date October 20, 2023
Est. primary completion date October 20, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years to 75 Years
Eligibility Inclusion Criteria: - Between the ages of 55 and 75 years - Body mass index (BMI) between 30-40 - Hemoglobin A1C level between 5.7 and 6.4% - Height between 60 and 74 inches tall - Adequate visual acuity or corrected visual acuity to read and perform computer tasks - Fluency in spoken and written English - Ability to walk independently for 20 minutes as per self-report. - Women must be postmenopausal (absence of menstruation for a minimum of 12-months or bilateral oophorectomy) - Willing to abstain from recreational drug use Exclusion Criteria: - Vegetarian or vegan - Cognitive impairment, memory loss, or neurologic/psychological disorder that interfere with activities of daily living - Muscle or mobility deficit that would interfere with walking independent for 20 minutes - Chronic conditions associated with increased risk of falls or falls within the last year that were not precipitated by unusual circumstances (e.g. slipping on ice, being pushed) - Gastrointestinal diseases, conditions, or medications influencing gastrointestinal absorption - Use of medications or dietary supplements known or suspected to influence study outcomes - Mini Mental State Exam (MMSE) score of less than 24 at screening - Diabetes mellitus diagnosis or fasting glucose >= 126 mg/dL or taking diabetes medication - Liver dysfunction, history of cirrhosis, or elevated SGPT, SGOT, or total bilirubin - Kidney disease as indicated by serum creatinine > 1.5 mg/dL at screening - Uncontrolled blood pressure - Cardiac or pulmonary conditions that limit ambulation or results in dyspnea with ambulation - Allergy to strawberry or ingredients in the placebo. - Ethanol use above 2 servings/day of beer (12-ounces), wine (5 ounces) or liquor (1.5 ounces), or binge-drinking - Recent inflammatory diseases (for example: rheumatoid arthritis, lupus) - Cigarette smoking, use of nicotine replacement products, or smoking of marijuana/consumption of edibles in past 3 months or during the course of the study - History of stomach or bowel resection (other than appendectomy), gastric bypass or other bariatric weight loss procedure - Cancer of any type (except for non-melanoma skin) in past 3 yrs or actively using cancer chemotherapeutic agents - Clotting/bleeding disorders or ongoing anticoagulant use - Bilateral mastectomy with nodal dissection - No social security number (unable to pay stipend) - Blood biochemistries outside of normal range - Prior participation in a study involving berry supplementation at our institution

Study Design


Intervention

Dietary Supplement:
Strawberry
12g freeze-dried strawberry (powder), twice daily with water, for 90 days
Other:
Placebo
12g red, strawberry-flavored powder, twice daily with water, for 90 days

Locations

Country Name City State
United States Tammy M Scott Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
USDA Human Nutrition Research Center on Aging California Strawberry Commission

Country where clinical trial is conducted

United States, 

References & Publications (4)

Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999 Sep 15;19(18):8114-21. doi: 10.1523/JNEUROSCI.19-18-08114.1999. — View Citation

Miller MG, Shukitt-Hale B. Berry fruit enhances beneficial signaling in the brain. J Agric Food Chem. 2012 Jun 13;60(23):5709-15. doi: 10.1021/jf2036033. Epub 2012 Feb 3. — View Citation

Miller MG, Thangthaeng N, Poulose SM, Shukitt-Hale B. Role of fruits, nuts, and vegetables in maintaining cognitive health. Exp Gerontol. 2017 Aug;94:24-28. doi: 10.1016/j.exger.2016.12.014. Epub 2016 Dec 21. — View Citation

Shukitt-Hale B, Bielinski DF, Lau FC, Willis LM, Carey AN, Joseph JA. The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing. Br J Nutr. 2015 Nov 28;114(10):1542-9. doi: 10.1017/S0007114515003451. Epub 2015 Sep 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Spatial Cognition Spatial cognition will be measured using a virtual navigation task. Change from baseline at 90 days
Secondary Gait Speed Preferred gait speed will be measured using an instrumented treadmill. Change from baseline at 90 days
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2